Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kuze

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Ryoikibetsu Shokogun Shirizu|March 1, 1994
[Young's syndrome]R Amitani, F Kuze
Kekkaku : [Tuberculosis]|August 1, 1983
[Sensitivities of atypical mycobacteria to various drugs. VI. Antibacterial effects of sulfonamides and their combinations in vitro]N Sakurai, F Kuze
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 10, 1994
[Infections likely to develop in the immunocompromised host: Mycobacterial infections]R Amitani, F Kuze
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 1, 1994
[Churg-Strauss syndrome]R Amitani, F Kuze
Kekkaku : [Tuberculosis]|November 1, 1994
[New drugs against tuberculosis and nontuberculous mycobacterial infections: a review]R Amitani, F Kuze
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1991
[Mucoid Pseudomonas aeruginosa infection in cystic fibrosis]R Amitani, F Kuze
Kekkaku : [Tuberculosis]|July 1, 1974
[Sensitivities of atypical mycobacteria to various drugs. II. Sensitivities to commonly used antibiotics, some of anti-neoplastic agents, an anti-leprotic and an antifungus agent (author's transl)]F Kuze, S Takeda, N Maekawa
Kekkaku : [Tuberculosis]|June 1, 1974
[Sensitivities of atypical mycobacteria to various drugs. I. Sensitivities to antituberculous drugs (author's transl)]F Kuze, S Takeda, N Maekawa
Kekkaku : [Tuberculosis]|January 1, 1978
[A study on experimental mycobacterioses provoked by atypical mycobacteria. 1. Pathogenicity of atypical myocbacteria for conventional mice--pathological processes by intravenous inoculation (author's transl)]F Kuze, N Maekawa, Y Suzuki
Kokyu to Junkan. Respiration & Circulation|December 1, 1992
[The present status of nontuberculous (atypical) mycobacterial infections]E Tanaka, R Amitani, F Kuze
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Ryoikibetsu Shokogun Shirizu|March 1, 1994
[Young's syndrome]R Amitani, F Kuze
Kekkaku : [Tuberculosis]|August 1, 1983
[Sensitivities of atypical mycobacteria to various drugs. VI. Antibacterial effects of sulfonamides and their combinations in vitro]N Sakurai, F Kuze
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 10, 1994
[Infections likely to develop in the immunocompromised host: Mycobacterial infections]R Amitani, F Kuze
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 1, 1994
[Churg-Strauss syndrome]R Amitani, F Kuze
Kekkaku : [Tuberculosis]|November 1, 1994
[New drugs against tuberculosis and nontuberculous mycobacterial infections: a review]R Amitani, F Kuze
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1991
[Mucoid Pseudomonas aeruginosa infection in cystic fibrosis]R Amitani, F Kuze
Kekkaku : [Tuberculosis]|July 1, 1974
[Sensitivities of atypical mycobacteria to various drugs. II. Sensitivities to commonly used antibiotics, some of anti-neoplastic agents, an anti-leprotic and an antifungus agent (author's transl)]F Kuze, S Takeda, N Maekawa
Kekkaku : [Tuberculosis]|June 1, 1974
[Sensitivities of atypical mycobacteria to various drugs. I. Sensitivities to antituberculous drugs (author's transl)]F Kuze, S Takeda, N Maekawa
Kekkaku : [Tuberculosis]|January 1, 1978
[A study on experimental mycobacterioses provoked by atypical mycobacteria. 1. Pathogenicity of atypical myocbacteria for conventional mice--pathological processes by intravenous inoculation (author's transl)]F Kuze, N Maekawa, Y Suzuki
Kokyu to Junkan. Respiration & Circulation|December 1, 1992
[The present status of nontuberculous (atypical) mycobacterial infections]E Tanaka, R Amitani, F Kuze
Pageof 12